Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

By J. Panés, D. García-Olmo, G. Van Assche, J. Colombel, W. Reinisch, Daniel C. Baumgart, A. Dignass, M. Nachury, M. Ferrante, L. Kazemi-Shirazi and 6 more. The Lancet, 2016

887 citations recorded by the source corpus.

Subfields: Dermatology, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/237d917cdd1eec4ffd05529725cd061e40a86086

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Jovicic
2. V. Djonov
3. N. Arsenijević
4. B. S. Marković
5. L. Armstrong
6. M. Gazdic
7. M. Stojkovic
8. M. Lako

Citations in the corpus

• Ethical and Safety Issues of Stem Cell-Based Therapy (2018, background): “Administration of autologous or allogeneic MSCs derived from BM and AT achieved significant clinical efficacy in patients with fistulazing CD by attenuating local immune response and by promoting tissue repair [51-58].”